Evidence map›Paper›PMID 38431514›Full record

ReviewTrends in biotechnology2024

Microbial electrosynthesis: opportunities for microbial pure cultures.

Falk Harnisch, Jörg S Deutzmann, Santiago T Boto, Miriam A Rosenbaum

Abstract readReview
In one paragraph

Review in Trends in biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. A small number of point mutations confer formate tolerance inApplied and environmental microbiology · 2025
    Article
  11. HBiotechnology and bioengineering · 2025
    Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Falk HarnischDepartment of Microbial Biotechnology, Helmholtz Centre for Environmental Research GmbH, Permoserstrasse 15, 04318 Leipzig, Germany.
Jörg S DeutzmannDepartment of Civil and Environmental Engineering, Stanford University, Stanford, CA, USA.
Santiago T BotoLeibniz Institute for Natural Product Research and Infection Biology, Hans-Knöll-Institute, Adolf Reichwein Strasse 23, 07745 Jena, Germany; Institute of Microbiology, Faculty for Biological Sciences, Friedrich-Schiller-University Jena, Neugasse 23, 07743 Jena, Germany.
Miriam A RosenbaumLeibniz Institute for Natural Product Research and Infection Biology, Hans-Knöll-Institute, Adolf Reichwein Strasse 23, 07745 Jena, Germany; Institute of Microbiology, Faculty for Biological Sciences, Friedrich-Schiller-University Jena, Neugasse 23, 07743 Jena, Germany. Electronic address: miriam.rosenbaum@leibniz-hki.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbial electrosynthesis (MES) is an emerging technology that couples renewable electricity to microbial production processes. Although advances in MES performance have been driven largely by microbial mixed cultures, we see a great limitation in the diversity, and hence value, of products that can be achieved in undefined mixed cultures. By contrast, metabolic control of pure cultures and genetic engineering could greatly expand the scope of MES, and even of broader electrobiotechnology, to include targeted high-value products. To leverage this potential, we advocate for more efforts and activities to develop engineered electroactive microbes for synthesis, and we highlight the need for a standardized electrobioreactor infrastructure that allows the establishment and engineering of electrobioprocesses with these novel biocatalysts.

Indexed as

Bioelectric Energy SourcesBacteriaBioreactorsBiotechnologyGenetic EngineeringMetabolic Engineeringelectrobioproductionelectrobioreactorelectrobiotechnologymicrobial electromethanogenesismicrobial electrosynthesismicrobial pure culture

Identifiers

PMID38431514
PMCPMC11310912

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.